Systemic conditioned medium treatment from interleukin-1 primed mesenchymal stem cells promotes recovery after stroke

BACKGROUND: Mesenchymal stem cells (MSCs) hold great potential as a therapy for stroke and have previously been shown to promote recovery in preclinical models of cerebral ischaemia. MSCs secrete a wide range of growth factors, chemokines, cytokines and extracellular vesicles—collectively termed the...

Descripción completa

Detalles Bibliográficos
Autores principales: Cunningham, Catriona J., Wong, Raymond, Barrington, Jack, Tamburrano, Sabrina, Pinteaux, Emmanuel, Allan, Stuart M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6975095/
https://www.ncbi.nlm.nih.gov/pubmed/31964413
http://dx.doi.org/10.1186/s13287-020-1560-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6975095/
https://www.ncbi.nlm.nih.gov/pubmed/31964413
http://dx.doi.org/10.1186/s13287-020-1560-y

Ejemplares similares